World Encouraged by Moderna Vaccine’s Success in Trials
Moderna Inc.’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer Inc.’s vaccine, …